Elfat Rumman
Internal Medicine · Apache Junction, AZNPI 1811266208
Payments from drug & device makers
Across 154 payments — averaging $20.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$489
- Lilly USA, LLC$234
- Pfizer$187
- AbbVie$160
- GSK$139
- plus $855 from 21 others
What the payments were for
- Food & beverage$3,13299%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 72 | $1,093 |
| AstraZeneca | 16 | $489 |
| Lilly USA, LLC | 5 | $234 |
| Pfizer | 6 | $187 |
| AbbVie(2 entities) | 11 | $160 |
| GSK | 8 | $139 |
| Eisai Inc. | 2 | $137 |
| Amgen | 6 | $113 |
| Lucid Diagnostics Inc. | 1 | $84 |
| Boston Scientific | 3 | $83 |
| Radius Health, Inc. | 4 | $68 |
| Boehringer Ingelheim | 3 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Abiomed | 1 | $32 |
| Gilead | 1 | $27 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Currax Pharmaceuticals LLC | 1 | $25 |
| Merck | 1 | $23 |
| Abbott | 1 | $21 |
| Biogen | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,157 in reported general payments places this provider in the 85th percentile of 2,212 internal medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 11 | $16,519 |
| Atorvastatin Calcium | 78 | $767 |
| Levothyroxine Sodium | 50 | $575 |
| Gabapentin | 25 | $514 |
| Losartan Potassium | 65 | $467 |
| Amlodipine Besylate | 46 | $418 |
| Rosuvastatin Calcium | 21 | $411 |
| Metoprolol Succinate | 16 | $383 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $350 |
| Pantoprazole Sodium | 23 | $315 |
| Amitriptyline Hcl | 11 | $292 |
| Trazodone Hcl | 26 | $218 |
| Valsartan | 11 | $215 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $209 |
| Sertraline Hcl | 22 | $185 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $234 | $16,51911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,212 internal medicine providers in Arizona.
Other internal medicine in Apache Junction
- Yessica SachdevaMesa$13.7M
- Louise TaberPhoenix$8.5M
- Janelle WeyerChandler$5.5M
- Robert MutterperlTucson$5.3M
- Jalal AbbasSun City West$4.8M
- Nebojsa SkrepnikTucson$4.7M
- Philip MathewTempe$4.1M
- Justin MoserScottsdale$3.9M
- Franz RischardTucson$3.7M
- Randall SeveranceChandler$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.